Effect of weight loss on muscle lipid content in morbidly obese subjects

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 4 47-4, 2003, Pages

  Gray, Robert E ^a   Tanner, Charles J ^a   Pories, Walter J ^a   MacDonald, Kenneth G ^a   Houmard, Joseph A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Insulin resistance; Obesity; Skeletal muscle; Triglyceride

Indexed keywords

LIPID;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPID COMPOSITION; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE LEVEL; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 0037376857     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00371.2002     Document Type: Article

References (35)

1. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targer G, Alberiche M, Bonadonna RC, and Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47: 1643-1649, 1998.
2. Essen B, Jansson E, Henriksson J, Taylor AW, and Saltin B. Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol Scand 95: 153-165, 1975.
3. Evans WJ, Phinney SD, and Young VR. Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14: 101-102, 1982.
4. Goodpaster BH, He J, Watkins S, and Kelley DE. Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
5. Goodpaster BH, Thaete FL, Simoneau JA, and Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46: 1579-1585, 1997.
6. Goodpaster BH, Theriault R, Watkins SC, and Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49: 467-472, 2000.
7. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, S Camastra, and Ferrannini E. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51: 144-151, 2002.
8. Guesbeck NR, Hickey MS, MacDonald KG, Pories WJ, Harper I, Ravussin E, Dohm GL, and Houmard JA. Substrate utilization during exercise in formerly obese women. J Appl Physiol 90: 1007-1012, 2001.
9. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, and Dohm GL. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol Endocrinol Metab 268: E453-E457, 1995.
10. Hickey MS, Weidner MD, Gavigan KE, Zheng D, Tyndall GL, and Houmard JA. The insulin action-fiber type relationship in humans is muscle group specific. Am J Physiol Endocrinol Metab 269: E150-E154, 1995.
11. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maeker E, Tatthaei S, Schick F, Claussen C-D, and Haring H-U. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119, 1999.
12. James DE, Jenkins AB, and Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol Endocrinol Metab 248: E567-E574, 1985.
13. Kelley DE and Goodpaster BH. Skeletal muscle triglyceride: an aspect of regional adiposity and insulin resistance. Diabetes Care 24: 933-941, 2001.
14. Kelley DE, Goopaster BH, Wing RR, and Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
15. Kempen KP, Saris WH, Kuipers H, Glatz JF, and van der Vusse GJ. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content. Eur J Clin Invest 28: 1030-1037, 1998.
16. Kim J-Y, Hickner RC, Cortright RL, Dohm GL, and Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000.
17. 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
18. Malenfant P, Joanisse DR, Theriault R, Goodpaster BH, Kelley DE, and Simoneau JA. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes 25: 1316-1321, 2001.
19. Malenfant P, Tremblay A, Coucet E, Imbeault P, Simoneau J-A, and Joanisse DR. Elevated intramyocelluar lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 280: E632-E639, 2001.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function form fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 442-449, 1985.
21. Novikoff AF, Schin W, and Drucker J. Mitochondrial localization of oxidation enzymes: staining result with two tetrazolium salts. J Histochem Cytochem 9: 47-61, 1961.
22. Odusote K, Karpati G, and Carpenter S. An experimental morphometric study of neutral lipid accumulation in skeletal muscles. Muscle Nerve 4: 3-9, 1981.
23. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
24. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Gestolin G, Pozza G, Del Maschio A, and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes 48: 1600-1606, 1999.
25. Phillips DI, Caddy S, v. Ilic Fielding BA, Frayn KN, Borthwick AC, and Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-950, 1996.
26. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel RG, Dolezal JM, and Dohm GL. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222: 339-352, 1995.
27. Ross R, Pedwell H, and Rissanen J. Effects of energy restriction and exercise on skeletal muscle and adipose tissue in women as measured by magnetic resonance imaging. Am J Clin Nutr 61: 1179-1185, 1995.
28. Russell DM, Walker PM, Leiter LA, Sima AA, Tanner WK, Mickle DA, Whitwell J, Marliss EB, and Jeejeebhoy KN. Metabolic and structural changes in skeletal muscle during hypocaloric dieting. Am J Clin Nutr 39: 503-513, 1984.
29. Saltin B and Gollnick PD. Skeletal muscle adaptability: significance for metabolism and performance. In: Handbook of Physiology: Skeletal Muscle, edited by Peachy LDE, Adrian RH, and Geiger SR. Baltimore, MD: Williams and Wilkins, 1983, p. 551-631.
30. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
31. Simoneau JA, Colberg SR, Thaete FL, and Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 9: 273-278, 1995.
32. Simoneau JA, Veerkamp JH, Turcotte LP, and Kelley DE. Markers of the capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13: 2051-2060, 1999.
33. 1H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977-E989, 1999.
34. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, Cunningham PRG, Swanson MS, and Houmard JA. Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282: E1191-E1196, 2002.
35. Wattenberg LW and Leong JL. Effect of coenzyme Q10 and menadione on succinate dehydrogenase activity as measured by tetrazolium salt reduction. J Histochem Cytochem 8: 269-303, 1960.